An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment

S Drożdżal, J Rosik, K Lechowicz, F Machaj… - Drug Resistance …, 2021 - Elsevier
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …

FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy

S Drożdżal, J Rosik, K Lechowicz, F Machaj… - Drug resistance …, 2020 - Elsevier
In December 2019, a novel SARS-CoV-2 coronavirus emerged, causing an outbreak of life-
threatening pneumonia in the Hubei province, China, and has now spread worldwide …

[HTML][HTML] The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era

H Fan, F Lou, J Fan, M Li, Y Tong - The Lancet Microbe, 2022 - thelancet.com
The quest for effective drugs to treat COVID-19 has been a priority since the outbreak of the
disease. The clinical application of remdesivir has been greatly restricted by the need for …

An update on antiviral therapy against SARS-CoV-2: how far have we come?

O Indari, S Jakhmola, E Manivannan… - Frontiers in …, 2021 - frontiersin.org
COVID-19 pandemic has spread worldwide at an exponential rate affecting millions of
people instantaneously. Currently, various drugs are under investigation to treat an …

Old and re-purposed drugs for the treatment of COVID-19

SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …

Systematic review on the therapeutic options for COVID-19: clinical evidence of drug efficacy and implications

AR Abubakar, IH Sani, B Godman… - Infection and drug …, 2020 - Taylor & Francis
Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …

Comparative evaluation of authorized drugs for treating Covid‐19 patients

T Islam, M Hasan, MS Rahman… - Health Science …, 2022 - Wiley Online Library
Abstract Background and Aims Vaccines are the first line of defense against coronavirus
disease 2019 (Covid‐19). However, the antiviral drugs provide a new tool to fight the Covid …

Recent progress of antiviral therapy for coronavirus disease 2019

M Zhao, J Zhang, H Li, Z Luo, J Ye, Y Xu… - European journal of …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic has become a global public
health crisis, for which antiviral treatments are considered mainstream therapeutic …

Current pharmacological treatments for SARS-COV-2: A narrative review

G Nittari, G Pallotta, F Amenta, SK Tayebati - European Journal of …, 2020 - Elsevier
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in
November 2019, quickly spread around the world becoming a pandemic. Despite the …

Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof)

P Vijayvargiya, ZE Garrigos, NEC Almeida… - Mayo Clinic …, 2020 - Elsevier
The novel severe acute respiratory syndrome coronavirus 2 is causing a worldwide
pandemic that may lead to a highly morbid and potentially fatal coronavirus disease 2019 …